ArticlePloS one2026
Analysis of ovarian cancer immune cell profile identifies immunosuppressive states associated with adverse clinical attributes and survival times.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The ovarian tumor microenvironment (TME) is highly immunosuppressive, limiting immunotherapy effectiveness. We investigated whether the composition, ratios, and polarization of infiltrating immune cells provide prognostic value in ovarian cancer (OC). Our analysis revealed that immune ratios, including CD8/Treg and CD8/CD4, were more predictive of survival than absolute CD8 + , CD4 + , or Treg levels. Prior studies have reported associations between higher CD8/Treg ratios and improved responses to immune checkpoint inhibitors, highlighting the importance of effector-regulator balance; however, immunotherapy response was not evaluated in this cohort. Additionally, macrophage polarization proved to be crucial: pro-tumor M2-macrophages were associated with vascular invasion, persistent tumor, and worse survival, while higher naïve M0-macrophage levels predicted improved outcomes. Surprisingly, anti-tumor M1-macrophages lacked prognostic significance, suggesting possible benefits in preserving an M0-macrophage pool. Neutrophil infiltration, though relatively uncommon, correlated with poor survival, supporting reports that neutrophils suppress T-cell responses. Immune infiltration was linked to aggressive features such as vascular invasion, reflecting both heightened recognition and compensatory recruitment of suppressive populations. Unsupervised clustering identified four immune-defined subtypes, with worse survival in clusters enriched for M2-macrophages and CD4 + T-cells and depleted in M0-macrophages, particularly in advanced disease. Overall, our findings highlight the prognostic value of immune ratios, macrophage polarization, and neutrophil activity in OC, suggesting new avenues for risk stratification and future therapeutic investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.